Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology consensus statement

The Korean Society of Gynecologic Oncology (KSGO) had been making an effort to standardize and enhance the quality of domestic uterine corpus cancer treatment by developing updated clinical practice guidelines in 2021. The KSGO revised the guidelines based on a literature search using 4 key elements...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of gynecologic oncology Vol. 35; no. 2; p. e45
Main Authors:	Kim, Ju-Hyun, Kim, Dae-Yeon, Kim, Junhwan, Noh, Joseph J, Hwang, Woo Yeon, Baek, Min-Hyun, Choi, Min Chul, Joo, Won Duk, Lee, Yong Jae, Suh, Dong Hoon, Kim, Yong Beom
Format:	Journal Article
Language:	English
Published:	Korea (South) Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 01-03-2024 대한부인종양학회
Subjects:	Endometrial Neoplasms - pathology Female Humans Lymph Node Excision Lymph Nodes - pathology Neoplasm Recurrence, Local - pathology Neoplasm Staging Practice Guideline Republic of Korea Sentinel Lymph Node - pathology Sentinel Lymph Node Biopsy Uterine Neoplasms - pathology 산부인과학 Republic of Korea Sentinel Lymph Node Immune Checkpoint Inhibitor Survival Surgery Endometrial Neoplasm Trastuzumab
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	The Korean Society of Gynecologic Oncology (KSGO) had been making an effort to standardize and enhance the quality of domestic uterine corpus cancer treatment by developing updated clinical practice guidelines in 2021. The KSGO revised the guidelines based on a literature search using 4 key elements: Population, Intervention, Comparison, and Outcome framework. These elements include the evaluation of the efficacy and safety of immune checkpoint inhibitor treatment in recurrent/advanced endometrial cancer patients who have failed platinum-based chemotherapy, as well as the effect of combined treatment with trastuzumab in patients with HER2/neu-positive endometrial cancer. Additionally, the guideline assessed the efficacy and safety of omitting lymph node dissection in low-risk endometrial cancer patients, investigated the effect of sentinel lymph node mapping in early-stage endometrial cancer surgery, addressed the outcome of chemoradiation therapy as a postoperative treatment in patients with advanced (stage III-IVA) endometrial cancer, and explored the impact of initial treatment with immune checkpoint inhibitors on survival in patients with advanced or recurrent endometrial cancer patients.
AbstractList	The Korean Society of Gynecologic Oncology (KSGO) had been making an effort tostandardize and enhance the quality of domestic uterine corpus cancer treatment bydeveloping updated clinical practice guidelines in 2021. The KSGO revised the guidelinesbased on a literature search using 4 key elements: Population, Inter vention, Comparison,and Outcome framework. These elements include the evaluation of the efficacy and safety ofimmune checkpoint inhibitor treatment in recurrent/advanced endometrial cancer patientswho have failed platinum-based chemotherapy, as well as the effect of combined treatmentwith trastuzumab in patients with HER2/neu-positive endometrial cancer. Additionally,the guideline assessed the efficacy and safety of omitting lymph node dissection in low-riskendometrial cancer patients, investigated the effect of sentinel lymph node mapping inearly-stage endometrial cancer surger y, addressed the outcome of chemoradiation therapy asa postoperative treatment in patients with advanced (stage III–IVA) endometrial cancer, andexplored the impact of initial treatment with immune checkpoint inhibitors on sur vival inpatients with advanced or recurrent endometrial cancer patients. KCI Citation Count: 0 The Korean Society of Gynecologic Oncology (KSGO) had been making an effort to standardize and enhance the quality of domestic uterine corpus cancer treatment by developing updated clinical practice guidelines in 2021. The KSGO revised the guidelines based on a literature search using 4 key elements: Population, Intervention, Comparison, and Outcome framework. These elements include the evaluation of the efficacy and safety of immune checkpoint inhibitor treatment in recurrent/advanced endometrial cancer patients who have failed platinum-based chemotherapy, as well as the effect of combined treatment with trastuzumab in patients with HER2/neu-positive endometrial cancer. Additionally, the guideline assessed the efficacy and safety of omitting lymph node dissection in low-risk endometrial cancer patients, investigated the effect of sentinel lymph node mapping in early-stage endometrial cancer surgery, addressed the outcome of chemoradiation therapy as a postoperative treatment in patients with advanced (stage III–IVA) endometrial cancer, and explored the impact of initial treatment with immune checkpoint inhibitors on survival in patients with advanced or recurrent endometrial cancer patients. The committee of uterine corpus cancer of the Korean Society of Gynecologic Oncology developed updated guideline for treatments of uterine corpus cancer patients. Evidences of recommendation according to each key question were evaluated using systematic review and meta-analysis. The Korean Society of Gynecologic Oncology (KSGO) had been making an effort to standardize and enhance the quality of domestic uterine corpus cancer treatment by developing updated clinical practice guidelines in 2021. The KSGO revised the guidelines based on a literature search using 4 key elements: Population, Intervention, Comparison, and Outcome framework. These elements include the evaluation of the efficacy and safety of immune checkpoint inhibitor treatment in recurrent/advanced endometrial cancer patients who have failed platinum-based chemotherapy, as well as the effect of combined treatment with trastuzumab in patients with HER2/neu-positive endometrial cancer. Additionally, the guideline assessed the efficacy and safety of omitting lymph node dissection in low-risk endometrial cancer patients, investigated the effect of sentinel lymph node mapping in early-stage endometrial cancer surgery, addressed the outcome of chemoradiation therapy as a postoperative treatment in patients with advanced (stage III-IVA) endometrial cancer, and explored the impact of initial treatment with immune checkpoint inhibitors on survival in patients with advanced or recurrent endometrial cancer patients.
Author	Noh, Joseph J Suh, Dong Hoon Kim, Dae-Yeon Kim, Junhwan Choi, Min Chul Baek, Min-Hyun Kim, Yong Beom Hwang, Woo Yeon Joo, Won Duk Lee, Yong Jae Kim, Ju-Hyun
AuthorAffiliation	4 Center for Gynecologic Cancer, National Cancer Center, Goyang, Korea 2 Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea 3 Department of Obstetrics and Gynecology, School of Medicine, Kyung Hee University Medical Center, Kyung Hee University, Seoul, Korea 5 Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, College of Medicine, CHA University, Seongnam, Korea 7 Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea 6 Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea 1 Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
AuthorAffiliation_xml	– name: 3 Department of Obstetrics and Gynecology, School of Medicine, Kyung Hee University Medical Center, Kyung Hee University, Seoul, Korea – name: 4 Center for Gynecologic Cancer, National Cancer Center, Goyang, Korea – name: 2 Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea – name: 6 Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea – name: 1 Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea – name: 7 Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea – name: 5 Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, College of Medicine, CHA University, Seongnam, Korea
Author_xml	– sequence: 1 givenname: Ju-Hyun orcidid: 0000-0003-4007-5739 surname: Kim fullname: Kim, Ju-Hyun organization: Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea – sequence: 2 givenname: Dae-Yeon orcidid: 0000-0003-0180-9314 surname: Kim fullname: Kim, Dae-Yeon email: kdyog@amc.seoul.kr organization: Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. kdyog@amc.seoul.kr – sequence: 3 givenname: Junhwan orcidid: 0000-0001-6807-1233 surname: Kim fullname: Kim, Junhwan organization: Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea – sequence: 4 givenname: Joseph J orcidid: 0000-0002-3132-8709 surname: Noh fullname: Noh, Joseph J organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea – sequence: 5 givenname: Woo Yeon orcidid: 0000-0003-0231-8330 surname: Hwang fullname: Hwang, Woo Yeon organization: Department of Obstetrics and Gynecology, School of Medicine, Kyung Hee University Medical Center, Kyung Hee University, Seoul, Korea – sequence: 6 givenname: Min-Hyun orcidid: 0000-0003-0423-9038 surname: Baek fullname: Baek, Min-Hyun organization: Center for Gynecologic Cancer, National Cancer Center, Goyang, Korea – sequence: 7 givenname: Min Chul orcidid: 0000-0003-4509-6731 surname: Choi fullname: Choi, Min Chul organization: Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, College of Medicine, CHA University, Seongnam, Korea – sequence: 8 givenname: Won Duk orcidid: 0000-0003-4637-6946 surname: Joo fullname: Joo, Won Duk organization: Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, College of Medicine, CHA University, Seongnam, Korea – sequence: 9 givenname: Yong Jae orcidid: 0000-0003-0297-3116 surname: Lee fullname: Lee, Yong Jae organization: Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea – sequence: 10 givenname: Dong Hoon orcidid: 0000-0002-4312-966X surname: Suh fullname: Suh, Dong Hoon organization: Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea – sequence: 11 givenname: Yong Beom orcidid: 0000-0003-1196-369X surname: Kim fullname: Kim, Yong Beom organization: Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/38216137$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003060799$$DAccess content in National Research Foundation of Korea (NRF)
BookMark	eNpVkd1rFDEUxYNU7Ic--yZ5FGG3d5KZTOKLlKK1WKhofQ7Z5M6YdibZJjPCvvqXm92ti0LgHrjn_HLhnJKjEAMS8rqCJZfAzu_7uGTA6iVvllg3z8gJA2gWwJU6OmgJx-Q053sA0YJkL8gxl6wSFW9PyO-vydjJW6T97B0OPmCmXUx0NMH0OGKYaOzoPGEqK2pjWs-ZWhMsJuoD_RITmvfU7EWg36P1OG22matNQBuH2HtLb8NObQogZAy5MPJkph3_JXnemSHjq6d5Rn58-nh3-Xlxc3t1fXlxs7Cc13zBjLN8tQJXcS4U71xXdc4BtA2rGgbKOCastC2sQEgj2kp0RjHrrBLCtSV1Rt7tuSF1-sF6HY3fzT7qh6Qvvt1d6wrq8kAU84e9eT2vRnS23JnMoNfJjyZtdtH_N8H_LKBfhaBqqaQqhLdPhBQfZ8yTHn22OAwmYJyzZoop4FzWrFjP91abYs4Ju8M_Fehtz7r0rLc9a97o0nNJvPn3vIP_b7H8DzXlqH8
Cites_doi	10.1016/j.ejso.2018.06.034 10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P 10.1245/s10434-017-5816-4 10.1016/j.annonc.2023.10.034 10.1136/bmj.328.7454.1490 10.1136/jitc-2021-003777 10.1056/NEJMoa2302312 10.1016/j.ygyno.2019.03.254 10.1016/S0140-6736(08)61766-3 10.1016/j.ygyno.2017.01.013 10.1056/NEJMoa1813181 10.1093/jnci/djn397 10.1158/1078-0432.CCR-20-0953 10.1056/NEJMoa2108330 10.1016/j.ygyno.2018.08.022 10.3802/jgo.2019.30.e38 10.1056/NEJMoa2216334
ContentType	Journal Article
Copyright	2024. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology. 2024. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology 2024 Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology
Copyright_xml	– notice: 2024. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology. – notice: 2024. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology 2024 Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology
DBID	CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM ACYCR
DOI	10.3802/jgo.2024.35.e45
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index (Open Access)
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	2005-0399
EndPage	e45
ExternalDocumentID	oai_kci_go_kr_ARTI_10410406 10_3802_jgo_2024_35_e45 38216137
Genre	Journal Article Review
GeographicLocations	Republic of Korea
GeographicLocations_xml	– name: Republic of Korea
GrantInformation_xml	– fundername: National Cancer Center grantid: NCC-2112570-3 – fundername: ; grantid: NCC-2112570-3
GroupedDBID	29K 2WC 5-W 53G 5GY 8JR 8XY 9ZL AAKDD ABDBF ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CGR CUY CVF D-I DIK DU5 E3Z EBD ECM EF. EIF F5P GROUPED_DOAJ HYE HZB M~E NPM OK1 RPM AAYXX CITATION 7X8 5PM ABMYL ACYCR
ID	FETCH-LOGICAL-c3343-2adc3bb0d133693fdf1fdd0075215209ad26c8c70b068a6716fa92cdc966d7d13
IEDL.DBID	RPM
ISSN	2005-0380
IngestDate	Sun Mar 17 03:18:43 EDT 2024 Tue Apr 09 21:55:21 EDT 2024 Sat Oct 26 05:11:29 EDT 2024 Fri Aug 23 01:36:09 EDT 2024 Sat Nov 02 12:20:26 EDT 2024
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	2
Keywords	Sentinel Lymph Node Immune Checkpoint Inhibitor Survival Surgery Endometrial Neoplasm Trastuzumab
Language	English
License	2024. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c3343-2adc3bb0d133693fdf1fdd0075215209ad26c8c70b068a6716fa92cdc966d7d13
Notes	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 https://doi.org/10.3802/jgo.2024.35.e45
ORCID	0000-0003-4007-5739 0000-0001-6807-1233 0000-0003-4637-6946 0000-0003-0297-3116 0000-0003-4509-6731 0000-0003-0180-9314 0000-0002-3132-8709 0000-0002-4312-966X 0000-0003-1196-369X 0000-0003-0231-8330 0000-0003-0423-9038
OpenAccessLink	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10948989/
PMID	38216137
PQID	2929033842
PQPubID	23479
PageCount	13
ParticipantIDs	nrf_kci_oai_kci_go_kr_ARTI_10410406 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10948989 proquest_miscellaneous_2929033842 crossref_primary_10_3802_jgo_2024_35_e45 pubmed_primary_38216137
PublicationCentury	2000
PublicationDate	2024-03-01
PublicationDateYYYYMMDD	2024-03-01
PublicationDate_xml	– month: 03 year: 2024 text: 2024-03-01 day: 01
PublicationDecade	2020
PublicationPlace	Korea (South)
PublicationPlace_xml	– name: Korea (South)
PublicationTitle	Journal of gynecologic oncology
PublicationTitleAlternate	J Gynecol Oncol
PublicationYear	2024
Publisher	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 대한부인종양학회
Publisher_xml	– name: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology – name: 대한부인종양학회
References	Eskander (10.3802/jgo.2024.35.e45_ref15) 2023; 388 Parkin (10.3802/jgo.2024.35.e45_ref1) 1999; 80 Colombo (10.3802/jgo.2024.35.e45_ref19) 2023; 34 Fader (10.3802/jgo.2024.35.e45_ref6) 2020; 26 Matei (10.3802/jgo.2024.35.e45_ref14) 2019; 380 Oaknin (10.3802/jgo.2024.35.e45_ref17) 2022; 10 Buda (10.3802/jgo.2024.35.e45_ref9) 2018; 44 Higgins (10.3802/jgo.2024.35.e45_ref3) 2016; 10 Schlappe (10.3802/jgo.2024.35.e45_ref10) 2018; 151 Lim (10.3802/jgo.2024.35.e45_ref2) 2019; 30 Atkins (10.3802/jgo.2024.35.e45_ref4) 2004; 328 Makker (10.3802/jgo.2024.35.e45_ref5) 2022; 386 Schiavone (10.3802/jgo.2024.35.e45_ref11) 2017; 24 Westin (10.3802/jgo.2024.35.e45_ref18) 2023 Bogani (10.3802/jgo.2024.35.e45_ref13) 2019; 153 ASTEC study group (10.3802/jgo.2024.35.e45_ref8) 2009; 373 Benedetti Panici (10.3802/jgo.2024.35.e45_ref7) 2008; 100 Mirza (10.3802/jgo.2024.35.e45_ref16) 2023; 388 How (10.3802/jgo.2024.35.e45_ref12) 2017; 144
References_xml	– volume: 44 start-page: 1562 year: 2018 ident: 10.3802/jgo.2024.35.e45_ref9 publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2018.06.034 contributor: fullname: Buda – year: 2023 ident: 10.3802/jgo.2024.35.e45_ref18 publication-title: J Clin Oncol contributor: fullname: Westin – volume: 80 start-page: 827 year: 1999 ident: 10.3802/jgo.2024.35.e45_ref1 publication-title: Int J Cancer doi: 10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P contributor: fullname: Parkin – volume: 24 start-page: 1965 year: 2017 ident: 10.3802/jgo.2024.35.e45_ref11 publication-title: Ann Surg Oncol doi: 10.1245/s10434-017-5816-4 contributor: fullname: Schiavone – volume: 34 start-page: S1281 year: 2023 ident: 10.3802/jgo.2024.35.e45_ref19 publication-title: Ann Oncol doi: 10.1016/j.annonc.2023.10.034 contributor: fullname: Colombo – volume: 328 start-page: 1490 year: 2004 ident: 10.3802/jgo.2024.35.e45_ref4 publication-title: BMJ doi: 10.1136/bmj.328.7454.1490 contributor: fullname: Atkins – volume: 10 start-page: e003777 year: 2022 ident: 10.3802/jgo.2024.35.e45_ref17 publication-title: J Immunother Cancer doi: 10.1136/jitc-2021-003777 contributor: fullname: Oaknin – volume: 388 start-page: 2159 year: 2023 ident: 10.3802/jgo.2024.35.e45_ref15 publication-title: N Engl J Med doi: 10.1056/NEJMoa2302312 contributor: fullname: Eskander – volume: 153 start-page: 676 year: 2019 ident: 10.3802/jgo.2024.35.e45_ref13 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2019.03.254 contributor: fullname: Bogani – volume: 10 start-page: 29 year: 2016 ident: 10.3802/jgo.2024.35.e45_ref3 publication-title: Cochrane Database Syst Rev contributor: fullname: Higgins – volume: 373 start-page: 125 year: 2009 ident: 10.3802/jgo.2024.35.e45_ref8 publication-title: Lancet doi: 10.1016/S0140-6736(08)61766-3 contributor: fullname: ASTEC study group – volume: 144 start-page: 503 year: 2017 ident: 10.3802/jgo.2024.35.e45_ref12 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2017.01.013 contributor: fullname: How – volume: 380 start-page: 2317 year: 2019 ident: 10.3802/jgo.2024.35.e45_ref14 publication-title: N Engl J Med doi: 10.1056/NEJMoa1813181 contributor: fullname: Matei – volume: 100 start-page: 1707 year: 2008 ident: 10.3802/jgo.2024.35.e45_ref7 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djn397 contributor: fullname: Benedetti Panici – volume: 26 start-page: 3928 year: 2020 ident: 10.3802/jgo.2024.35.e45_ref6 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-20-0953 contributor: fullname: Fader – volume: 386 start-page: 437 year: 2022 ident: 10.3802/jgo.2024.35.e45_ref5 publication-title: N Engl J Med doi: 10.1056/NEJMoa2108330 contributor: fullname: Makker – volume: 151 start-page: 235 year: 2018 ident: 10.3802/jgo.2024.35.e45_ref10 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2018.08.022 contributor: fullname: Schlappe – volume: 30 start-page: e38 year: 2019 ident: 10.3802/jgo.2024.35.e45_ref2 publication-title: J Gynecol Oncol doi: 10.3802/jgo.2019.30.e38 contributor: fullname: Lim – volume: 388 start-page: 2145 year: 2023 ident: 10.3802/jgo.2024.35.e45_ref16 publication-title: N Engl J Med doi: 10.1056/NEJMoa2216334 contributor: fullname: Mirza
SSID	ssj0067082
Score	2.35217
SecondaryResourceType	review_article
Snippet	The Korean Society of Gynecologic Oncology (KSGO) had been making an effort to standardize and enhance the quality of domestic uterine corpus cancer treatment... The Korean Society of Gynecologic Oncology (KSGO) had been making an effort tostandardize and enhance the quality of domestic uterine corpus cancer treatment...
SourceID	nrf pubmedcentral proquest crossref pubmed
SourceType	Open Website Open Access Repository Aggregation Database Index Database
StartPage	e45
SubjectTerms	Endometrial Neoplasms - pathology Female Humans Lymph Node Excision Lymph Nodes - pathology Neoplasm Recurrence, Local - pathology Neoplasm Staging Practice Guideline Republic of Korea Sentinel Lymph Node - pathology Sentinel Lymph Node Biopsy Uterine Neoplasms - pathology 산부인과학
Title	Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology consensus statement
URI	https://www.ncbi.nlm.nih.gov/pubmed/38216137 https://www.proquest.com/docview/2929033842 https://pubmed.ncbi.nlm.nih.gov/PMC10948989 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003060799
Volume	35
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
ispartofPNX	Journal of Gynecologic Oncology, 2024, 35(2), , pp.1-13
link	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6xPSAuiDfhURnBgUt2vbbjJNxQaSlChUqAxM1y7LhdynpXu-TQK7-cGSdZtYgTUqRY8ivJZ8ff2PMAeOW8ExZpRx6Kuc1VqUKOLJ_nHueStZVGSk_Gycdfyk_fq3eH5CZHj7YwSWnfNYtp_LmcxsV50q1cL91s1BObnZ4czFEmobCHswlMkByOMnr__9UlTyGiko9NLiveO_TBhJj9OCN7P6Gmspi2iqLWyEog56Eo6FeWpUnchH8xzr8VJ6-sREd34PZAIdnb_lHvwo023oObJ8Mh-X34fTpYPrGzjpxYkWI7Q27KljtVF7YKjGI5YBZD8XPdbZkj-DdsEdnHFRLJN8z2icgGxU6q8_4ytq7_XbLPMaUusQHan95iG8k6idp_AN-ODr8eHOdDqIXcSalkLqx3smm4R5FV1zL4MA_eE5-guLe8tl5oV7mSN1xXVqOQFWwtEGiUlnyJtR7CXlzF9jGwWolGFqUonNOqtg4RbwtJ4dcrq4LgGbwev7RZ9x41DEoihI9BfAzhY2RhEJ8MXiIS5sItDHnBpjsWuNgY5PofsJLCi-sMXoxIGZwbdOBhY7vqtkYg9-MogyuRwaMeuV2XI_AZVNcw3RWgHq_n4HBM_rfH4ffk_6s-hVv0nr0y2zPY-7Xp2ucw2fpuP-0K7Kch_QeNOvuG
link.rule.ids	230,315,729,782,786,866,887,27933,27934,53800,53802
linkProvider	National Library of Medicine
linkToHtml	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6xRQIuvEvD0wgOXLLrtR0n4YZKy1btlkoUiZvl2ElZ2vWudsmhV345M3msWsSpUqRYcmwr-sbJ9yXzAHjvvBMWaUdcJWMbq1RVMbJ8HnvcS9ZmGik9BSdPvqXHP7LPe5QmR_exMI3Tvitmw3AxH4bZz8a3cjl3o95PbHQy3R2jJqGyh6MB3MYNy3mv0tsnsE55UySqybLJsb9N6YMNMfp1RhF_Qg1lMiwV1a2RmUDWQ3XQr7yYBmFV_Y9z_us6eeVdtP_gpnfxEO537JN9avsfwa0yPIY70-7_-hP4c9IFTbGzmvJfkU88Q1rL5hsvGbaoGJWBwC6GynVZr5kjy1mxWWCHC-SgH5ltG4F1PqE05stlKF37pGVfQ9O6xAno0_Ya52gCm2j-p_B9f-90dxJ3VRpiJ6WSsbDeyaLgHtWuzmXlq3HlPVERKpnLc-uFdplLecF1ZjXqs8rmAm0EhZZPcdQ2bIVFKHeA5UoUMklF4pxWuXVoLGUiqXJ7ZlUleAQfeojMsk3GYVDEELAGgTUErJGJQWAjeIcQmnM3M5RAm854wfnKoEw4wEEKD64jeNtDbHBb0b8SG8pFvTYCaSNH-a5EBM9ayDdL9hYTQXbNGDYX0IrXe9AGmtTdPebPbz70DdydnE6PzNHB8eELuEf33PrEvYSt36u6fAWDta9fNzviL1vyEGk
linkToPdf	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9QwFH5iilRxYaekbEZw4JKJx3a23lDboVVpGQmQuFmOHZehHc9ohhx65ZfzXjIZtYgTSJESyZui7zn5vuQtAG-ts8Ig7Yh9OjKxypWPkeXz2OFeMqbIkNJTcPLR5_zsW3FwSGly9vpYmNZp31bTYbicDcP0e-tbuZjZpPcTSyan-yPUJFT2MFk4nwzgNm5aLnql3j2Fs5y3haLaTJsc27u0PtQx-XFOUX9CDWU6rBXVrpGFQOZDtdCvvZwGYen_xjv_dJ-89j4a3_ufO7kPd9cslL3v-jyAW3V4CNun6__sj-DXZB08xc4byoNFvvEM6S2bbbxl2NwzKgeBTQwV7KJZMUsWtGTTwE7myEX3mOkuAlv7htKYD1ehtt0Tl30K7dUVTkCfuFc4RxvgRPM_hq_jwy_7R_G6WkNspVQyFsZZWVXcoerNSumdH3nniJJQ6VxeGicyW9icVzwrTIY6zZtSoK2g4HI5jnoCW2Ee6qfASiUqmeYitTZTpbFoNHUqqYJ7YZQXPIJ3PUx60SXl0ChmCFyN4GoCV8tUI7gRvEEY9YWdakqkTWfscLHUKBeOcZDCg2cRvO5h1ri96J-JCfW8WWmB9JGjjFcigp0O9s2SvdVEUNwwiE0HWvFmC9pBm8K7x33334e-gu3JwVh_PD47eQZ36JY717jnsPVz2dQvYLByzct2U_wG5vsS6Q
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Practice+guidelines+for+management+of+uterine+corpus+cancer+in+Korea%3A+a+Korean+Society+of+Gynecologic+Oncology+consensus+statement&rft.jtitle=Journal+of+gynecologic+oncology&rft.au=Kim%2C+Ju-Hyun&rft.au=Kim%2C+Dae-Yeon&rft.au=Kim%2C+Junhwan&rft.au=Noh%2C+Joseph+J&rft.date=2024-03-01&rft.eissn=2005-0399&rft.volume=35&rft.issue=2&rft.spage=e45&rft.epage=e45&rft_id=info:doi/10.3802%2Fjgo.2024.35.e45&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2005-0380&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2005-0380&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2005-0380&client=summon